TickerFactsScreenerDevelopers

VERTEX PHARMACEUTICALS INC / MA (VRTX) — Net Income

Annual figures by fiscal year, from SEC filings.

2009: -$642.18M2010: -$754.63M2011: $29.57M2012: -$107.03M2013: -$445.03M2014: -$738.55M2015: -$556.33M2016: -$112.05M2017: $263.48M2018: $2.10B2019: $1.18B2020: $2.71B2021: $2.34B2022: $3.32B2023: $3.62B2024: -$535.60M2025: $3.95B$3.95B
2009Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025$3.95B+838.1%
2024-$535.60M-114.8%
2023$3.62B+9.0%
2022$3.32B+41.8%
2021$2.34B-13.6%
2020$2.71B+130.4%
2019$1.18B-43.9%
2018$2.10B+695.8%
2017$263.48M+335.1%
2016-$112.05M+79.9%
2015-$556.33M+24.7%
2014-$738.55M-66.0%
2013-$445.03M-315.8%
2012-$107.03M-461.9%
2011$29.57M+103.9%
2010-$754.63M-17.5%
2009-$642.18M—